{
  "actions": [
    {
      "acted_at": "2023-06-21",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2023-06-21",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2023-06-23",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr4242-118",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "118",
  "cosponsors": [
    {
      "bioguide_id": "K000389",
      "district": "17",
      "name": "Khanna, Ro",
      "original_cosponsor": true,
      "sponsored_at": "2023-06-21",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001215",
      "district": "1",
      "name": "Miller-Meeks, Mariannette",
      "original_cosponsor": true,
      "sponsored_at": "2023-06-21",
      "state": "IA",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2023-06-21",
  "number": "4242",
  "official_title": "To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.",
  "popular_title": null,
  "related_bills": [],
  "short_title": null,
  "sponsor": {
    "bioguide_id": "C001120",
    "district": "2",
    "name": "Crenshaw, Dan",
    "state": "TX",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2023-06-21",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Alternative treatments",
    "Department of Health and Human Services",
    "Drug therapy",
    "Drug, alcohol, tobacco use",
    "Health",
    "Medical research"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2023-06-21",
    "date": "2024-07-19T19:39:44Z",
    "text": "This bill requires the Food and Drug Administration (FDA) to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy, including how to request support from the FDA for related investigational use exemptions."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.",
      "type": "official"
    }
  ],
  "updated_at": "2024-07-24T15:21:19Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/hr/BILLSTATUS-118hr4242.xml"
}